Xiaochun Qin

机构：Shenyang Pharmaceutical University, Jiangnan University, Jiangsu University, Beijing Jiaotong University, First People's Hospital of Kunshan, Guigang City People's Hospital, Tianjin Medical University · ORCID：0000-0001-5436-0501

发表论文 23 篇 · 总被引 430 次 · h-index 11

代表论文

• PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma (2020 · Pharmacological Research · 被引 140)
• Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo (2020 · Life Sciences · 被引 41)
• A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway (2020 · Cell Death and Disease · 被引 35)
• DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer (2022 · Frontiers in Oncology · 被引 29)
• Cimicifuga dahurica extract inhibits the proliferation, migration and invasion of breast cancer cells MDA-MB-231 and MCF-7 in vitro and in vivo (2021 · Journal of Ethnopharmacology · 被引 24)
• Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo (2018 · Biomedicine & Pharmacotherapy · 被引 24)